2009年6月
Reduced ability of hemagglutinin of the CAM-70 measles virus vaccine strain to use receptors CD46 and SLAM
VACCINE
- ,
- ,
- ,
- ,
- ,
- ,
- ,
- ,
- ,
- 巻
- 27
- 号
- 29
- 開始ページ
- 3838
- 終了ページ
- 3848
- 記述言語
- 英語
- 掲載種別
- 研究論文(学術雑誌)
- DOI
- 10.1016/j.vaccine.2009.04.010
- 出版者・発行元
- ELSEVIER SCI LTD
The CAM-70 measles Virus (MV) vaccine strain is Currently used for vaccination against measles. We examined the fusion-inducing ability of the CAM-70 hemagglutinin (H) protein and found that it was impaired in both CD46- and signaling lymphocyte activation molecule (SLAM)-expressing cells. We also generated recombinant MVs possessing H genes derived from the CAM-70 strain. The CAM-70 H protein impaired viral growth in both CD46- and SLAM-expressing cells. In peripheral blood lymphocytes (PBL) and monocyte-derived dendritic cells (Mo-DC), the CAM-70 strain did not grow efficiently. Infection with recombinant MVs revealed that impaired growth of the CAM-70 strain was attributed to the H gene only partly in PBL and largely in Mo-DC. Thus, impaired fusion-inducing ability of the H protein may be one of the underlying molecular mechanisms resulting in the attenuation of the CAM-70 strain. (C) 2009 Elsevier Ltd. All rights reserved.
Web of Science ® 被引用回数 : 8
Web of Science ® の 関連論文(Related Records®)ビュー
- リンク情報
- ID情報
-
- DOI : 10.1016/j.vaccine.2009.04.010
- ISSN : 0264-410X
- Web of Science ID : WOS:000267581300006